Acceleration of lipid peroxidation in α-tocopherol transfer protein-knockout mice following the consumption of drinking water containing a radical initiator

Journal of Oleo Science

Volumn 57, Issue 10, 2008, Pages 577-583

  Yoshida, Yasukazu ^a   Hayakawa, Mieko ^a   Cynshi, Osamu ^b   Jishage, Kou Ichi ^b   Niki, Etsuo ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Free radicals; Lipid peroxidation; Total hydroxyoctadecadienoic acid (tHODE)

Indexed keywords

EID: 56649112633     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.57.577     Document Type: Article

References (20)

1. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine, 3rd ed. Oxford University Press, Oxford (1999).
2. Niki, E.; Yoshida, Y.; Saito, Y.; Noguchi, N. Lipid peroxidation: Mechanisms, inhibition, and biological effects. Biochem. Biophys. Res. Commun. 338, 668-676 (2005).
3. Traber, M.G.; Frei, B.; Beckman, J.S. Vitamin E revisited: Do new data validate benefits for chronic disease prevention? Curr. Opin. Lipidol. 19, 30-38, (2008).
4. Bursell, S.E.; Clermont, A.C.; Aiello, L.P.; Aiello, L.M.; Schlossman, D.K.; Feener, E.P.; Laffel, L.; King, G.L. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22, 1245-1251 (1999).
5. Johnson, L.; Quinn, G.E.; Abbasi, S.; Gerdes, J.; Bowen, F.W.; Bhutani, V. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: Incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. J. Pediatr. 127, 632-639 (1995).
6. Pasantes-Morales, H.; Quiroz, H.; Quesada, O. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: A 3-year follow-up study. Metab. Brain Dis. 17,183-197 (2002).
7. Sano, M.; Ernesto, C.; Thomas, R.G.; Klauber, M.R.; Schafer, K.; Grundman, M.; Woodbury, P.; Growdon, J.; Cotman, C.W.; Pfeiffer, E.; Schneider, L.S.; Thal, L.J. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med. 336, 1216-1222 (1997).
8. Arita, M.; Nomura, K.; Arai, H.; Inoue, K. α-Tocopherol transfer protein stimulates the secretion of α-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway. Proc. Natl. Acad. Sci. U. S. A. 94, 12437-12441 (1997).
9. Ouahchi, K.; Arita, M.; Kayden, H.; Hentati, F.; Ben Hamida, M.; Sokol, R.; Arai, H.; Inoue, K.; Mandel, J.L.; Koenig, M. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat. Genet. 9, 141-145 (1995).
10. Gotoda, T.; Arita, M.; Arai, H.; Inoue, K.; Yokota, T.; Fukuo, Y.; Yazaki, Y.; Yamada, N. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N. Engl. J. Med. 333, 1313-1318 (1995).
11. Jishage, K.; Arita, M.; Igarashi, K.; Iwata, T.; Watanabe, M.; Ogawa, M.; Ueda, O.; Kamada, N.; Inoue, K.; Arai, H.; Suzuki, H. α-Tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J. Biol. Chem. 276, 1669-1672 (2001).
12. Yoshida, Y.; Itoh, N.; Hayakawa, M.; Habuchi, Y.; Inoue, R.; Chen, Z.H. Cao, J.; Cynshi, O.; Niki, E. Lipid peroxidation in mice fed a choline-deficient diet as evaluated by total hydroxyoctadecadienoic acid. Nutr. 22, 303-311 (2006).
13. Yoshida, Y.; Niki E. Detection of lipid peroxidation in vivo: Total hydroxyoctadecadienoic acid and 7-hydroxycholesterol as oxidative stress marker. Free Rad. Res. 38, 787-794 (2004).
14. Yoshida, Y.; Kodai S.; Takemura, S.; Minamiyama, Y.; Niki, E. Simultaneous measurements of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Anal. Biochem. in press (2008).
15. Tanito, M.; Itoh, N.; Yoshida, Y.; Hayakawa, M.; Ohira, A.; Niki, E. Distribution of tocopherols and tocotrienols to rat ocular tissues after topical ophthalmic administration. Lipids 39, 469-474 (2004).
16. Yoshida, Y.; Itoh, N.; Saito, Y.; Hayakawa, M.; Niki, E. Application of water soluble initiator, 2,2′-azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride, to a study of oxidative stress. Free Rad. Res. 38, 375-384 (2004).
17. Noguchi, N.; Yamashita, H.; Hamahara, J.; Nakamura, A.; Kuhn, H.; Niki, E. The specificity of lipoxygenase-catalyzed lipid peroxidation and the effects of radical-scavenging antioxidants. Biol. Chem. 383, 619-626 (2002).
18. Yoshida, Y.; Hayakawa, M.; Niki, E. Total hydroxyoctadecadienoic acid as a marker for lipid peroxidation in vivo. BioFactors 24, 7-15, (2005).
19. Morrow, J.D. Quantifications of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 25, 279-286 (2005).
20. Mezzetti, A.; Cipollone, F.; Cuccurullo, F. Oxidative stress and cardiovascular complications in diabetes: Isoprostanes as new markers on an old paradigm. Cardiovasc. Res. 47, 475-488 (2000).